In the rapidly accelerating field of ophthalmology research, working with Ora’s experts can reduce the risk profile of drug development and increase the likelihood of getting approval. Whether you're in early stage animal efficacy, PK, or tolerability, Ora is the only Ophthalmic CRO that can take you from preclinical through Phase III all in one place. Our in-house experts will select the ideal indication for your MOA, analyze market and regulatory conditions, and position your drug or device to enter the clinic quickly.

Call us at: 978.685.8900

At Ora, we support the drug development process during the preclinical stage by selecting the appropriate disease indication and determining relevant preclinical animal models.
The folllowing errors need to be corrected before the form can be submitted.
*First Name
*Last Name
*Email Address
*Phone Number
Comment